当前位置:首页 >财报库 > 报告详情

山德士Sandoz 2025年前三季度(9M)财报-净销售额「瑞士证券交易所」(英文版)(36页).pdf

上传人: 1****1 编号:998597 2025-12-23 36页 2.39MB

下载:

1、9M 2025 sales updateOctober 30,2025DisclaimerThis presentation contains forward-looking statements,which offer no guarantee with regard to future performance.These statements are made on the basis of managements views and assumptions regarding future events and business performance at the time the s

2、tatements are made.They are subject to risks and uncertainties including,but not confined to,future global economic conditions,exchange rates,legal provisions,market conditions,activities by competitors and other factors outside of the control of Sandoz.Should one or more of these risks or uncertain

3、ties materialize or should underlying assumptions prove incorrect,actual outcomes may vary materially from those forecasted or expected.Each forward-looking statement speaks only as of the date of the particular statement,and Sandoz undertakes no obligation to publicly update or revise any forward-l

4、ooking statements,except as required by law.This presentation includes non-IFRS financial measures as defined by Sandoz.An explanation of non-IFRS measures can be found in the Supplementary financial information of the Half-Year Report 2025.Certain figures contained in this presentation,including fi

5、nancial information presented in billions or millions,certain operating data and percentages describing financial information or market shares,have been subject to rounding.Dollar values and percentages may not agree to totals.9M 2025 sales updateAgenda9M 2025 sales update1.Highlights and business u

6、pdateRichard Saynor,CEO Net-sales performance and 2025 guidanceRemco Steenbergen,CFO Wrap-up Richard Saynor,CEOQuestionsRichard Saynor,CEO|Remco Steenbergen,CFO 2.3.4.3Highlights and business updateRichard SaynorChief Executive OfficerSales-growth acceleration underpinning momentum9M 2025 sales upda

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据《9M 2025销售更新》报告,以下是Sandoz公司关键点概括: 1. 净销售额增长:2025年前三季度净销售额同比增长5%至8.1亿瑞士法郎,同比增长6%至7%。 2. 生物类似药增长:生物类似药销售额占比31%,同比增长13%。 3. 地区表现:欧洲、国际和北美地区均实现增长。 4. 产品亮点:Wyost® & Jubbonti®、Pyzchiva®、Omnitrope®等新产品表现强劲。 5. 研发管线:拥有超过400项在研资产,预计未来十年带来约2200亿美元的潜在销售额。 6. 财务状况:资产负债表稳健,流动性良好,支持未来增长。
"2025年销售更新有哪些亮点?" "Sandoz如何推动生物类似药的增长?" "未来十年,仿制药和生物类似药的前景如何?"
客服
商务合作
小程序
服务号
折叠